Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Sleep aids are pills and medical devices that are used in the diagnosis and treatment of sleep disorders. Sleep aids consist of various products such as medications, sleep laboratories, sleep apnea devices, and mattresses & pillows. Medications generally include drugs, which help induce sleep by restraining activities in the central nervous system.

The global sleep aids market is estimated to account for US$ 80,814.7 Mn in terms of value and is expected to reach US$ 118,825.4 Mn by the end of 2027.

Global Sleep Aids Market: Drivers

Increasing prevalence of sleep disorders is expected to propel growth of the global sleep aids market over the forecast period. For instance, according to the study, ‘Worldwide and Regional Prevalence Rates of Co-Occurrence of Insomnia and Insomnia Symptoms With Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis’ published in February 2019, the overall prevalence rates of insomnia, any insomnia complaints, difficulty falling asleep, difficulty maintaining sleep, and early morning awakening found in obstructive sleep apnea patients were 38%, 36%, 18%, 42%, and 21%, respectively.

Moreover, increasing geriatric population is also expected to aid in growth of the market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034.     

Insomnia held dominant position in the global sleep aids market in 2019, accounting for 30.1% share in terms of value, followed by sleep apnoea and restless legs syndrome, respectively

Figure 1. Global Sleep Aids Market Share (%), by Value, by Sleep Disorder, 2019

Sleep Aids  | Coherent Market Insights

Global Sleep Aids Market: Restraints

Side effects associated with sleep aid medications are expected to hinder growth of the market.  The most common side effects associated with sleep aids medication are constipation, dizziness, headache, heartburn, dry mouth, and stomach pain. These side effects are associated with OTC as well as prescription-based sleep aids.

Moreover, patent expiration of major sleep disorder drugs is also expected to limit growth of the market.  Patent expiration is one of the major concerns for pharmaceutical companies, as loss of patents of various major drugs result in heavy decline in sales revenue.

request-sample

Sleep Aids Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 2,833.1 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 6.8% 2027 Value Projection: US$ 4,821.6 Mn
Geographies covered:
  • North America: U.S., Canada
  • Latin America: Brazil, Argentina, Mexico, Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, Rest of Asia Pacific
  • Middle East: GCC Countries, Israel, Rest of Middle East
  • Africa: South Africa, North Africa, Central Africa
Segments covered:
  • By Product Type: Medication, Sleep laboratories, Mattresses and pillows, Sleep apnea devices, Others.
  • By Sleep Disorder: Insomnia, Sleep apnea, Restless legs syndrome, Narcolepsy, Night terrors, Others.
Companies covered:

Sanofi S.A., Merck & Co., Inc., Pfizer, Inc., Koninklijke Philips N.V., GlaxoSmithKline Plc, Sommetrics, Inc., ResMed Inc., Cadwell Laboratories, Inc., Therapix Biosciences Ltd., SleepMed, Inc., Natus Medical Incorporated, DeVilbiss Healthcare LLC, and Compumedics Limited.

Growth Drivers:
  • Increasing prevalence of sleep disorders
  • Increasing product launches
Restraints & Challenges:
  • Side effects of drugs
  • Patent loss of medications

Global Sleep Aids Market: Opportunities

Increasing prevalence of lifestyle disorders is expected to offer lucrative growth opportunities for players in the global sleep aids market. For instance, according to the study, “Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition”, published in the journal Diabetes Research and Clinical Practice, in September 2019, 463 million people are expected to suffer from diabetes in 2019 worldwide and the number is expected to reach 578 million by 2030 and 700 million by 2045.

Moreover, increasing funding in sleep aids is also expected to aid in growth of the market. For instance, in June 2019, CVS Health, a US-based pharmacy benefit manager, announced to fund Sleepio app, an insomnia app, developed by Big Health.

The global sleep aids market was valued at US$ 80,814.7 Mn in 2019 and is forecast to reach a value of US$ 118,825.4 Mn by 2027 at a CAGR of 5.7% between 2020 and 2027.

Figure 2. Global Sleep Aids Market Value (US$ Mn), and Y-o-Y Growth (%), 2019-2027

Sleep Aids  | Coherent Market Insights

Market Trends/Key Takeaways

The marker is witnessing increasing adoption of sleep apps. For instance, in May 2020, Kaiser Permanente Corporate Office Headquarters announced it has added Calm, an app for mindfulness meditation and sleep, to its digital self-care portfolio.

The market is also witnessing development and launch of products that comply with regulatory guidelines. For instance, in May 2020, Sommetrics, Inc., a provider of products for the treatment of airway obstruction during sleep and in acute care settings, announced that its quality management system has been certified to the rigorous ISO 13485:2016 standard.

Global Sleep Aids Market: Competitive Landscape

Major players operating in the global sleep aids market include, Sanofi S.A., Merck & Co., Inc., Pfizer, Inc., Koninklijke Philips N.V., GlaxoSmithKline Plc, Sommetrics, Inc., ResMed Inc.,  Cadwell Laboratories, Inc., Therapix Biosciences Ltd., SleepMed, Inc., Natus Medical Incorporated, DeVilbiss Healthcare LLC, and Compumedics Limited.

Global Sleep Aids Market: Key Developments

Major players in the market are focused on launching new products to expand their product portfolio. For instance, in January 2020, ResMed Inc. launched AirFit F30i, its first tube-up full face CPAP mask.

Major players in the market are also focused on R&D of new products to expand their product portfolio.  For instance, in November 2019, Therapix Biosciences Ltd. announced topline results from its Phase IIa clinical study that demonstrated positive endpoints for THX-110, a combination of dronabinol (? -9-tetrahydracannabinol and CannAmide (palmitoylethanolamide), for treatment of obstructive sleep apnea.

Sleeping aids, also known as hypnotics are sleeping pills or devices, which are used to induce sleep. It is used in the treatment of various sleeping disorders such as narcolepsy, sleep apnea, and insomnia, which are caused due to factors such as psychiatric disorders (Depression and anxiety), environmental problems (light, noise and extreme temperatures) medical issues (asthma) and others. Sleeping aid medications include non-benzodiazepines, antidepressants, and antipsychotics for the treatment of sleeping disorders. However, various behavioral therapies such as light therapy, cognitive behavioral therapy, and relaxation techniques are also used in the treatment of these disorders. According to Centers for Disease Control and Prevention (CDC), in 2017, around 49.2 million people across the globe have trouble focusing due to lack of sleep.

Restraints of the Global Sleeping Aids Market

Major factors hampering the growth of the sleep aids market during the forecast period constitutes of side effects associated with sleep aid medications, and patent expirations of medications.

Key features of the study:

  • This report provides in-depth analysis of the global sleeping aids market and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018, as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by leading players
  • It profiles leading players in the global sleeping aids market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include Sanofi S.A., Merck & Co., Inc., Pfizer, Inc., Koninklijke Philips N.V., GlaxoSmithKline Plc, Sommetrics, Inc., ResMed Inc., Cadwell Laboratories, Inc., Therapix Biosciences Ltd., SleepMed, Inc., Natus Medical Incorporated, DeVilbiss Healthcare LLC, and Compumedics Limited.
  • Insights from this report would allow marketers and the management authorities of companies to make informed decision regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global sleeping aids market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the market.

Detailed Segmentation

  • Global Sleeping Aids Market, By Product Type:
    • Medication
    • Sleep laboratories
    • Mattresses and pillows
    • Sleep apnea devices
    • Others
  • Global Sleeping Aids Market, By Sleep Disorder:
    • Insomnia
    • Sleep apnea
    • Restless legs syndrome
    • Narcolepsy
    • Night terrors
    • Others
  • Global Sleeping Aids Market, By Geography:
    • North America
      • By Product Type
        • Medication
        • Sleep laboratories
        • Mattresses and pillows
        • Sleep apnea devices
        • Others
      • By Sleep Disorder:
        • Insomnia
        • Sleep apnea
        • Restless legs syndrome
        • Narcolepsy
        • Night terrors
        • Others
      • By Country:
        • U.S.
        • Canada
    • Europe
      • By Product Type
        • Medication
        • Sleep laboratories
        • Mattresses and pillows
        • Sleep apnea devices
        • Others
      • By Sleep Disorder:
        • Insomnia
        • Sleep apnea
        • Restless legs syndrome
        • Narcolepsy
        • Night terrors
        • Others
      • By Country:
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • By Product Type
        • Medication
        • Sleep laboratories
        • Mattresses and pillows
        • Sleep apnea devices
        • Others
      • By Sleep Disorder:
        • Insomnia
        • Sleep apnea
        • Restless legs syndrome
        • Narcolepsy
        • Night terrors
        • Others
      • By Country:
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • By Product Type
        • Medication
        • Sleep laboratories
        • Mattresses and pillows
        • Sleep apnea devices
        • Others
      • By Sleep Disorder:
        • Insomnia
        • Sleep apnea
        • Restless legs syndrome
        • Narcolepsy
        • Night terrors
        • Others
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East:
      • By Product Type
        • Medication
        • Sleep laboratories
        • Mattresses and pillows
        • Sleep apnea devices
        • Others
      • By Sleep Disorder:
        • Insomnia
        • Sleep apnea
        • Restless legs syndrome
        • Narcolepsy
        • Night terrors
        • Others
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • By Product Type
        • Medication
        • Sleep laboratories
        • Mattresses and pillows
        • Sleep apnea devices
        • Others
      • By Sleep Disorder:
        • Insomnia
        • Sleep apnea
        • Restless legs syndrome
        • Narcolepsy
        • Night terrors
        • Others
      • By Country/Region:
        • Central Africa
        • South Africa
        • North Africa
  • Company Profiles
    • Sanofi S.A.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Strategies
      • Recent Developments
    • Merck & Co., Inc.
    • Pfizer, Inc.
    • Koninklijke Philips N.V.
    • GlaxoSmithKline Plc
    • Sommetrics, Inc.
    • ResMed Inc.
    • Cadwell Laboratories, Inc.
    • Therapix Biosciences Ltd.
    • SleepMed, Inc.
    • Natus Medical Incorporated
    • DeVilbiss Healthcare LLC
    • Compumedics Limited

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Sleep Disorder
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Technological Advancement
    • Regulatory Scenario
  4. Global Sleep Aids Market, By Product Type, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Medication
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Sleep laboratories
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Mattresses and pillows
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Sleep apnea devices
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
      • Segment Trends
  5. Global Sleep Aids Market, By Sleep Disorder, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • Insomnia
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Sleep apnea
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Restless legs syndrome
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Narcolepsy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Night terrors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
  6. Global Sleep Aids Market, By Regions, 2017 – 2027 (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2019–2027
      • Segment Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2019 – 2027, (US$ Mn)
        • North Africa
        • Central Africa
        • South Africa
  7. Competitive Landscape
    • Company Profiles
      • Sanofi S.A.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Merck & Co., Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Pfizer, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Koninklijke Philips N.V.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • GlaxoSmithKline Plc
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Sommetrics, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • ResMed Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Cadwell Laboratories, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Therapix Biosciences Ltd.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • SleepMed, Inc.
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Natus Medical Incorporated
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • DeVilbiss Healthcare LLC
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Compumedics Limited
        • Company Overview
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
  8. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 35 market data tables and 26 figures on “Sleep Aids Market – Global forecast to 2027.

Frequently Asked Questions

The global sleep aids market was valued at US$ 80,814.7 Mn in 2019 and is forecast to reach a value of US$ 118,825.4 Mn by 2027 at a CAGR of 5.7% between 2020 and 2027.
Major factor driving the growth of global sleep aids market during the forecast period include increasing prevalence of sleep disorders, and increasing product launches.
Major factors hampering the growth of the sleep aids market during the forecast period constitutes of side effects associated with sleep aid medications, and patent expirations of medications.
Insomnia held dominant position in the global Sleep Aids market in 2019.
North America Sleep Aids market is expected to generate the highest revenue during the forecast period.
Some of the key players operating in the market are Sanofi S.A., Merck & Co., Inc., Pfizer, Inc., Koninklijke Philips N.V., GlaxoSmithKline Plc, Sommetrics, Inc., ResMed Inc., Cadwell Laboratories, Inc., Therapix Biosciences Ltd., SleepMed, Inc., Natus Medical Incorporated, DeVilbiss Healthcare LLC, and Compumedics Limited.
Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner